Factors Determining Collapsibility Of The Human Upper Airway During Sleep And General Anaesthesia
Funder
National Health and Medical Research Council
Funding Amount
$259,625.00
Summary
Obstructive sleep apnoea (OSA) is common, affecting between 2-4% of middle-aged adults. It is characterised by repetitive partial or complete collapse of the upper airway during sleep. Each episode is accompanied by transient hypoxemia, hypertension and arousal. The repetitive arousals disrupt sleep resulting in excessive daytime tiredness and lethargy, which have major consequences for social well-being and productivity in our community. OSA is an independent risk factor for vascular disease. C ....Obstructive sleep apnoea (OSA) is common, affecting between 2-4% of middle-aged adults. It is characterised by repetitive partial or complete collapse of the upper airway during sleep. Each episode is accompanied by transient hypoxemia, hypertension and arousal. The repetitive arousals disrupt sleep resulting in excessive daytime tiredness and lethargy, which have major consequences for social well-being and productivity in our community. OSA is an independent risk factor for vascular disease. Central to understanding OSA is knowledge of the mechanisms responsible for vulnerability to upper airway collapse. It remains unclear to what extent this vulnerability relates to abnormalities in the underlying structure and passive physical characteristics of the upper airway, versus abnormalities in activity of upper airway muscles. Making this distinction has been problematic because current methods of testing upper airway collapsibility in sleeping humans tend to result in changes in muscle activity and-or sleep state, affecting the measurements. It is, however, possible to suppress upper airway muscle activity and eliminate measurement-related changes in muscle activity and state with general anaesthesia, while maintaining normal spontaneous breathing. We have developed and refined this method and propose to use it in novel investigations to (a) relate the behaviour of the flaccid airway (no muscle activity) under anaesthesia to its behaviour during sleep (when muscle activity is variable but quantifiable), and (b) determine the effect of changes in body habitus (posture and lung volume) on airway collapsibility. These studies will allow examination of the exciting possibility that measurements made under brief general anaesthesia could be used to define propensity to obstruction during sleep. They will also allow examination of the contribution of common changes in body habitus toward vulnerability to upper airway collapse.Read moreRead less
The Effect Of CPAP On Erectile And Endothelial Dysfunction In Impotent Men With Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$609,559.00
Summary
Erectile dysfunction is common in men with obstructive sleep apnea, due to vascular damage, which leads to heart attack. CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will establish if CPAP can also improve erectile and vascular endothelial dysfunction. These results will shed light on the mechanisms that underpin the relationship between OSA and Erectile Dysfunction.
Spirometry And Asthma Management In Children And Adults In General Practice.
Funder
National Health and Medical Research Council
Funding Amount
$500,000.00
Summary
Measurement of airflow obstruction, as measured by spirometry, is a vital element in the management of people with asthma. This study aims to examine the potential benefits to patients of using spirometry in the management of asthma in children and adults.
Protecting The Endothelial Glycocalyx To Improve Transplant Rates And Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$725,180.00
Summary
A tiny, previously overlooked, structure called the endothelial glycocalyx (EG) is now known to ‘waterproof’ blood vessels. This grant extends our exciting preliminary data in the field of lung transplantation, where we have shown that EG loss is the main cause of a poorly functioning organ, to develop new tests of lung and kidney function, as well as treatments to resuscitate marginal organs outside the body, so improving access to and the safety of transplantation.
Pregabalin And Speech Pathology Treatment For Refractory Chronic Cough With Laryngeal Hypersensitivity
Funder
National Health and Medical Research Council
Funding Amount
$155,747.00
Summary
Persistent cough that does not respond to medical treatment is debilitating and frustrating for the sufferer and very expensive for the Australian government. This research will provide a new and effective treatment option and extend our current reputation as the world leader in the identification and treatment of refractory chronic cough. This treatment strategy has not been trialled before and the findings will change current medical practice and significantly reduce community health costs.
Dynamic In Vivo Size & Shape Measurement Of The Human Upper Airway Using Endoscopic Long-range Optical Coherence Tomogra
Funder
National Health and Medical Research Council
Funding Amount
$184,250.00
Summary
This project will fund the construction of a clinically deployable prototype device to measure changes in upper airway size and shape in patients with obstructive sleep apnoea. We have recently developed and validated a technique based on endoscopic optical coherence tomography (OCT). Preliminary in vivo studies have been performed in the human upper airway and the results published. To our knowledge, this is the only such system world-wide capable of making these important measurements. The tec ....This project will fund the construction of a clinically deployable prototype device to measure changes in upper airway size and shape in patients with obstructive sleep apnoea. We have recently developed and validated a technique based on endoscopic optical coherence tomography (OCT). Preliminary in vivo studies have been performed in the human upper airway and the results published. To our knowledge, this is the only such system world-wide capable of making these important measurements. The technique has wide commercially applicability as it can be used to measure the internal dimensions of any hollow organ system.Read moreRead less
Pulmonary hypertension is a disease affecting the blood vessels in the lungs that causes severe shortness of breath and early death. Genetic mutations are known to cause this disease but the precise link between these mutations and the changes in the lungs are poorly understood. If we could understand this process better, we could design better treatments. This project will look at how the cells in the lungs communicate with each other and how this process is disturbed in pulmonary hypertension.
Novel Pharmacological Strategies To Treat Cognitive Dysfunction In COPD
Funder
National Health and Medical Research Council
Funding Amount
$872,455.00
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a major incurable global health burden and is the 4th largest cause of death worldwide. Up to 60% of COPD patients suffer from cognitive dysfunction (i.e. a brain disorder which affects learning, memory, attention) which often leads to dementia. The reason for this is unknown so the aim of this study is to determine why people with COPD suffer from mental disorders then develop novel treatments to treat these disorders in COPD patients.
Endothelial Development From Pluripotent Stem Cells As A Means To Study Pathology In Pulmonary Artery Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$613,311.00
Summary
Pulmonary artery hypertension (PAH) is a fatal disease primarily affecting young adults. It is caused by a defect in cells that form the vessel that carries blood from the heart to the lungs. We will use stem cells made from the skin of PAH patients to examine why the blood vessel cells from these patients fail to function normally.